14
Views
23
CrossRef citations to date
0
Altmetric
Original Article

Quantitative Studies of Gastric Endocrine Cells in Patients Receiving Long-term Treatment with Omeprazole

, , &
Pages 122-128 | Published online: 08 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (5)

Yanna Ko, James Tang, Santosh Sanagapalli, Bong Sik Matthew Kim & Rupert W Leong. (2016) Safety of proton pump inhibitors and risk of gastric cancers: review of literature and pathophysiological mechanisms. Expert Opinion on Drug Safety 15:1, pages 53-63.
Read now
Arne K Sandvik, Helge L Waldum & Eiliv Brenna. (2002) Long-term safety of proton pump inhibitors: risks of gastric neoplasia and infections. Expert Opinion on Drug Safety 1:1, pages 29-38.
Read now
M. Valentini, F. Bortoluzzi, C. Cernigoi, G. Toffoli, E. Bertolissi, R. Cannizzaro, M. Sozzi & M. Fornasarig. (1993) Effect of Short- and Long-Term Treatment with Omeprazole on Cell Cycle Distribution in the Gastric Mucosa: Results of a Flow Cytometric Study. Scandinavian Journal of Gastroenterology 28:7, pages 617-621.
Read now
H. F. Helander, K. Rutgersson, K. G. Helander, J. P. Pisegna, J. D Gardner, R. T. Jensen & P. N. Maton. (1992) Stereologic Investigations of Human Gastric Mucosa: II. Oxyntic Mucosa from Patients with Zollinger-Ellison Syndrome. Scandinavian Journal of Gastroenterology 27:10, pages 875-883.
Read now
K. G. Wormsley. (1991) Session 6: Is Hypergastrinaemia Dangerous for Man?. Scandinavian Journal of Gastroenterology 26:sup180, pages 174-178.
Read now

Articles from other publishers (18)

Silvia Maria Perrone CAMILO, Élia Cláudia de Souza ALMEIDA, Jacqueline Batista SOUSA, Luana Perrone CAMILO & Renata Margarida ETCHEBEHERE. (2020) CHRONIC USE OF PROTON PUMP INHIBITORS AND THE QUANTITY OF G, D, AND ECL CELLS IN THE STOMACH. ABCD. Arquivos Brasileiros de Cirurgia Digestiva (São Paulo) 33:2.
Crossref
Kyathanahalli S. Janardhan, Yvette Rebolloso, Geoffrey Hurlburt, David Olson, Otis Lyght, Natasha P. Clayton, Margarita Gruebbel, Catherine Picut, Cynthia Shackelford & Ronald A. Herbert. (2014) Histopathological and Immunohistochemical Characterization of Methyl Eugenol–induced Nonneoplastic and Neoplastic Neuroendocrine Cell Lesions in Glandular Stomach of Rats. Toxicologic Pathology 43:5, pages 681-693.
Crossref
Helge L. Waldum, Øyvind Hauso, Øystein F. Sørdal & Reidar Fossmark. (2014) Gastrin May Mediate the Carcinogenic Effect of Helicobacter pylori Infection of the Stomach. Digestive Diseases and Sciences 60:6, pages 1522-1527.
Crossref
Robert T. Jensen. (2006) Consequences of Long-Term Proton Pump Blockade: Insights from Studies of Patients with Gastrinomas. Basic <html_ent glyph="@amp;" ascii="&"/> Clinical Pharmacology <html_ent glyph="@amp;" ascii="&"/> Toxicology 98:1, pages 4-19.
Crossref
Paolo L. Peghini, Bruno Annibale, Cinzia Azzoni, Massimo Milione, Vito D. Corleto, Fathia Gibril, David J. Venzon, Gianfranco Delle Fave, Cesare Bordi & Robert T. Jensen. (2002) Effect of chronic hypergastrinemia on human enterochromaffin-like cells: Insights from patients with sporadic gastrinomas. Gastroenterology 123:1, pages 68-85.
Crossref
Schenk, Kuipers, Klinkenberg-Knol, Bloemena, Nelis, Festen, Jansen, Biemond, Lamers & Meuwissen. (1998) Hypergastrinaemia during long-term omeprazole therapy: influences of vagal nerve function, gastric emptying and Helicobacter pylori infection . Alimentary Pharmacology & Therapeutics 12:7, pages 605-612.
Crossref
Heidi‐Ingrid MaaroosNiilo HavuPentti Sipponen. (2001) Follow‐Up of Helicobacter pylori Positive Gastritis and Argyrophil Cells Pattern During the Natural Course of Gastric Ulcer . Helicobacter 3:1, pages 39-44.
Crossref
Nobuo Omura, Hideyuki Kashiwagi, Teruaki Aoki, Kayoko Omura & Yasunori Fukuchi. (1997) Effects of enprostil on gastric endocrine secretion during chronic administration of lansoprazole. Journal of Gastroenterology 32:6, pages 740-746.
Crossref
I. David BoughJr.Jr., Robert Thayer Sataloff, Donald O. Castell, James R. Hills, R. Matthew Gideon & Joseph R. Spiegel. (1995) Gastroesophageal reflux laryngitis resistant to omeprazole therapy. Journal of Voice 9:2, pages 205-211.
Crossref
R. F. McCloy, R. Arnold, K. D. Bardhan, D. Cattan, E. Klinkenberg-Knol, P. N. Maton, R. H. Riddell, P. Sipponen & A. Walan. (1995) Pathophysiological effects of long-term acid suppression in man. Digestive Diseases and Sciences 40:S2, pages 96S-120S.
Crossref
James W. Freston, Kurt Borch, Stephen J. Brand, Enar Carlsson, W. Creutzfeldt, Rolf Håkanson, Lars Olbe, Enrico Solcia, John H. Walsh & M. Michael Wolfe. (1995) Effects of hypochlorhydria and hypergastrinemia on structure and function of gastrointestinal cells. Digestive Diseases and Sciences 40:S2, pages 50S-62S.
Crossref
Guillaume Cadiot, Th�r�se Lehy, Philippe Ruszniewski, Serge Bonfils & Michel Mignon. (1993) Gastric endocrine cell evolution in patients with Zollinger-Ellison syndrome. Digestive Diseases and Sciences 38:7, pages 1307-1317.
Crossref
David I. Soybel & Irvin M. Modlin. (1992) Implications of sustained suppression of gastric acid secretion. The American Journal of Surgery 163:6, pages 613-622.
Crossref
Kent D. Katz & Daniel Hollander. (1992) Practical pharmacology and cost-effective management of peptic ulcer disease. The American Journal of Surgery 163:3, pages 349-359.
Crossref
Tiziana D'Adda, Francesco P. Pilato, Marco Lazzaroni, Flavio Robutti, Gabriele Bianchi-Porro & Cesare Bordi. (1991) Ultrastructural morphometry of gastric endocrine cells before and after omeprazole. Gastroenterology 100:6, pages 1563-1570.
Crossref
J. E. Valenzuela, R. G. Berlin, W. J. Snape, T. L. Johnson, B. I. Hirschowitz, J. Colon-Pagan, R. S. Morse, J. Petrozza, G. M. Van Deventer, A. Cagliola, J. Whipple, R. Berman & T. J. Humphries. (1991) U.S. experience with omeprazole in duodenal ulcer. Digestive Diseases and Sciences 36:6, pages 761-768.
Crossref
M. G. ROBINSON & D. L. DECKTOR. (2007) Experience with omeprazole in erosive oesophagitis. Alimentary Pharmacology & Therapeutics 5, pages 69-77.
Crossref
J. Hotz. 1990. Motilitätsstörungen im oberen Gastrointestinaltrakt. Motilitätsstörungen im oberen Gastrointestinaltrakt 41 68 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.